Shinpoong Pharmaceutical Co.,Ltd (KRX: 019170)
South Korea
· Delayed Price · Currency is KRW 10,110
-260 (-2.51%)
Dec 20, 2024, 9:28 AM KST
Shinpoong Pharmaceutical Co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -35,989 | -57,325 | -35,377 | -11,584 | 5,003 | 5,324 | Upgrade
|
| Depreciation & Amortization | 12,028 | 11,908 | 12,803 | 12,675 | 12,208 | 12,314 | Upgrade
|
| Loss (Gain) From Sale of Assets | -12.26 | -39.65 | -18.31 | -49.02 | 29.96 | 386.17 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 703.23 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,366 | 1,011 | -845.62 | -253.64 | 868.38 | -72.59 | Upgrade
|
| Loss (Gain) on Equity Investments | 6,603 | 6,514 | 697.09 | -2,620 | -2,520 | -691.62 | Upgrade
|
| Provision & Write-off of Bad Debts | -2,820 | 2,939 | 1,395 | -937.06 | 621.88 | 3,958 | Upgrade
|
| Other Operating Activities | 10,830 | 9,834 | 6,692 | -58,525 | 9,727 | 3,551 | Upgrade
|
| Change in Accounts Receivable | 756.75 | 5,805 | -1,225 | 8,199 | 9,298 | 6,022 | Upgrade
|
| Change in Inventory | -2,741 | -7,049 | 972.41 | 1,774 | -248.1 | -3,924 | Upgrade
|
| Change in Accounts Payable | -1,599 | -2,295 | -435.91 | 3,385 | -9,525 | -3,025 | Upgrade
|
| Change in Other Net Operating Assets | -698.88 | 3,850 | -11,806 | -23,093 | -5,401 | -4,492 | Upgrade
|
| Operating Cash Flow | -12,276 | -24,848 | -26,444 | -71,028 | 20,062 | 19,351 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 3.68% | -39.63% | Upgrade
|
| Capital Expenditures | -5,056 | -14,888 | -5,323 | -4,425 | -2,654 | -12,074 | Upgrade
|
| Sale of Property, Plant & Equipment | 12.95 | 53.26 | 1.01 | 16.63 | 16.09 | 139.78 | Upgrade
|
| Sale (Purchase) of Intangibles | -371.51 | -142.52 | -334.9 | -953.63 | -338.43 | -2,106 | Upgrade
|
| Investment in Securities | 4,545 | -1,349 | 48,846 | 54,379 | -92,080 | -16,364 | Upgrade
|
| Other Investing Activities | 9,209 | 17 | 8.01 | 11.16 | 99.89 | 47.84 | Upgrade
|
| Investing Cash Flow | 8,339 | -16,309 | 43,197 | 49,028 | -94,957 | -30,656 | Upgrade
|
| Long-Term Debt Issued | - | 45,000 | - | 10,000 | 26,943 | 21,373 | Upgrade
|
| Long-Term Debt Repaid | - | -1,761 | -1,869 | -11,262 | -133,644 | -23,844 | Upgrade
|
| Net Debt Issued (Repaid) | -5,015 | 43,239 | -1,869 | -1,262 | -106,701 | -2,471 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 215,355 | - | Upgrade
|
| Common Dividends Paid | - | - | - | -5,156 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -0 | -23.16 | Upgrade
|
| Financing Cash Flow | -5,015 | 43,239 | -1,869 | -6,418 | 108,654 | -2,494 | Upgrade
|
| Foreign Exchange Rate Adjustments | -64.69 | 27.29 | -830.79 | 252.16 | -1,331 | 5.38 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | 0 | - | -0 | Upgrade
|
| Net Cash Flow | -9,017 | 2,109 | 14,054 | -28,166 | 32,428 | -13,795 | Upgrade
|
| Free Cash Flow | -17,333 | -39,736 | -31,767 | -75,453 | 17,408 | 7,276 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 139.24% | -75.96% | Upgrade
|
| Free Cash Flow Margin | -8.05% | -19.85% | -15.18% | -39.87% | 8.80% | 3.84% | Upgrade
|
| Free Cash Flow Per Share | -338.12 | -775.15 | -619.69 | -1471.90 | 345.89 | 145.61 | Upgrade
|
| Cash Interest Paid | 2,590 | 1,647 | 2.06 | 158.16 | 3,107 | 4,130 | Upgrade
|
| Cash Income Tax Paid | 538.22 | -2,962 | -554.25 | 65,648 | 472.25 | 3,521 | Upgrade
|
| Levered Free Cash Flow | -2,784 | -26,774 | -16,386 | -48,674 | 70,074 | -1,552 | Upgrade
|
| Unlevered Free Cash Flow | -1,151 | -25,700 | -16,348 | -48,548 | 71,915 | 1,020 | Upgrade
|
| Change in Net Working Capital | -4,820 | -7,043 | 2,232 | 46,903 | -57,858 | 616.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.